RTI Surgical, Inc. Overview
Pro stress-test →RTI Surgical (now operating as Evergen as of March 2026) is a medical device and tissue engineering company founded in 1998. The company operates in the Medical Equipment Manufacturing industry, specializing in orthopedic solutions and regenerative medicine products for surgical applications.
Strategic Profile
Pro stress-test →As a Contract Development and Manufacturing Organization (CDMO), Evergen positions itself for targeted growth in specialized clinical segments through scalable manufacturing and R&D collaborations with larger OEM and healthcare organizations. The company leverages tissue engineering innovation to address patient needs in orthopedic and surgical markets.
Competitive Landscape
Pro stress-test →RTI Surgical competes in a crowded market where larger players like B. Braun Medical generate significantly higher revenues ($3.3B+). Key competitors include established orthopedic device manufacturers and CDMO-focused providers. The company differentiates through specialized tissue engineering, regenerative medicine, and contract manufacturing services.
Industry Context
RTI Surgical, Inc. operates in Orthopedic surgical devices and regenerative medicine.
Key facts
Founded: 1998 · Headquarters: Alachua, US · Employees: 493 · Revenue: $280-312M (2024-2025 estimates) · Market cap: N/A